150 related articles for article (PubMed ID: 7566196)
1. Reimbursement and ESRD. The future of managed care and the ESRD program.
Latos D; White M
Nephrol News Issues; 1995 Jul; 9(7):11. PubMed ID: 7566196
[No Abstract] [Full Text] [Related]
2. Disease management of ESRD: a brave new world for product suppliers.
Kenley RS
Nephrol News Issues; 1998 May; 12(5 Suppl):27, 29. PubMed ID: 9652297
[No Abstract] [Full Text] [Related]
3. The direction of end-stage renal disease reimbursement in the United States.
Lockridge RS
Semin Dial; 2004; 17(2):125-30. PubMed ID: 15043614
[TBL] [Abstract][Full Text] [Related]
4. Carve-out contracting for ESRD: what are the opportunities and the risks?
Luckenbill L; O'Neill M
Nephrol News Issues; 1998 Sep; 12(9):13-6. PubMed ID: 9923291
[No Abstract] [Full Text] [Related]
5. ESRD delivery models. Case management from the payor perspective.
Brandley D
Nephrol News Issues; 1995 Jun; 9(6):35-6. PubMed ID: 7666932
[No Abstract] [Full Text] [Related]
6. Can we revitalize the ESRD program?
McFeeley T
Nephrol News Issues; 2004 Apr; 18(5):42-3, 47, 87. PubMed ID: 15125164
[No Abstract] [Full Text] [Related]
7. Development of provider networks for specific diseases.
Pristave RJ; Becker S; McCarthy LI
Health Care Innov; 1995; 5(4):9-12, 16-20, 32-7. PubMed ID: 10158141
[No Abstract] [Full Text] [Related]
8. Managed care is not the "cure-all" for improving quality and controlling costs in ESRD.
Amerling R
Nephrol News Issues; 1999 Apr; 13(4):46-7. PubMed ID: 10418448
[No Abstract] [Full Text] [Related]
9. Futuristic plans for ESRD--a new bundled payment system.
Michael M
Nephrol News Issues; 2005 Sep; 19(10):52, 54. PubMed ID: 16187649
[No Abstract] [Full Text] [Related]
10. Erythropoietin & ESRD payments: a promising policy outcome?
Roe W
Nephrol News Issues; 1989 Sep; 3(9):34-5. PubMed ID: 2682270
[No Abstract] [Full Text] [Related]
11. Bundled payment for ESRD--including ESAs in Medicare's dialysis package.
Iglehart JK
N Engl J Med; 2011 Feb; 364(7):593-5. PubMed ID: 21323538
[No Abstract] [Full Text] [Related]
12. Surviving change: Can the ESRD provisions in the SCHIP create a level playing field?
Gardner AV
Nephrol News Issues; 2007 Sep; 21(10):52-3. PubMed ID: 17918480
[No Abstract] [Full Text] [Related]
13. Challenges and directions for Medicare ESRD payment policy.
Ray NF; Ross M
Semin Nephrol; 2000 Nov; 20(6):565-76. PubMed ID: 11111858
[TBL] [Abstract][Full Text] [Related]
14. Will the doors to managed care open soon for ESRD patients?
Neumann ME
Nephrol News Issues; 1999 Jul; 13(7):35-6, 38. PubMed ID: 10647368
[No Abstract] [Full Text] [Related]
15. Finding the real meaning of "managed care" for the ESRD community.
Van Valkenburgh D
Nephrol News Issues; 1992 Nov; 6(11):18, 20, 57-8. PubMed ID: 1300420
[No Abstract] [Full Text] [Related]
16. "Freedom of choice" argument may end shielding ESRD from managed care.
Rubin RJ
Nephrol News Issues; 1997 Apr; 11(4):30. PubMed ID: 9287687
[No Abstract] [Full Text] [Related]
17. Pediatric ESRD patients & their special treatment challenges.
Cole BE
Nephrol News Issues; 1989 Aug; 3(8):30-2. PubMed ID: 2674728
[No Abstract] [Full Text] [Related]
18. Special treatment--the story of Medicare's ESRD entitlement.
Rettig RA
N Engl J Med; 2011 Feb; 364(7):596-8. PubMed ID: 21323539
[No Abstract] [Full Text] [Related]
19. Health care reform, managed care not necessarily threats to ESRD program.
Zawiski MA
Nephrol News Issues; 1994 Jul; 8(7):10-1. PubMed ID: 8047171
[No Abstract] [Full Text] [Related]
20. ESRD program at the crossroads of health care reform.
Neumann ME
Nephrol News Issues; 1993 Oct; 7(10):5, 40. PubMed ID: 8232632
[No Abstract] [Full Text] [Related]
[Next] [New Search]
